Long-term outcome of Q fever endocarditis

The Lancet Infectious Diseases

Volumn 11, Issue 2, 2011, Pages 81-

  Limmathurotsakul, Direk ^a   Cooper, Ben ^a,b   Peacock, Sharon J ^a   De Stavola, Bianca ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE;

DRUG TREATMENT FAILURE; ENDOCARDITIS; HUMAN; LETTER; PRIORITY JOURNAL; Q FEVER; RELAPSE; SEROLOGY; SURVIVAL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MIDDLE AGED; Q FEVER; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 78751699185     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70014-7     Document Type: Letter

References (3)

1. Million M, Thuny F, Richet H, Raoult D Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 2010, 10:527-535.
2. Fisher LD, Lin DY Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999, 20:145-157.
3. Beyersmann J, Wolkewitz M, Schumacher M The impact of time-dependent bias in proportional hazards modelling. Stat Med 2008, 27:6439-6454.